CASP3 and Miyoshi myopathy: Moreover, pretreatment with bortezomib markedly augmented the cytotoxic impact of BVDV on MM cell lines, indicating a synergistic effect resulting from the activation of the caspase-3-mediated apoptotic pathway (17).